… ambient dopaminergic tone rather than activating dopamine D 1 receptors independent of
… This multiple ascending-dose study was a double-blind, placebo-controlled trial wherein …

… We here show that dopaminergic modulation iFC of 6 striatal seeds resulted in a significant
functional decoupling from the right ventral caudate to both occipital fusiform gyri in …

… has been discussed in disorders ranging from schizophrenia … Frankfurt am Main as a
placebo-controlled, double-blind cross-… is modulated by a challenge of the dopamine system using …

… , a dysfunction in the ability to modulate the DA system in a context-dependent manner is
proposed to underlie the inappropriate interpretation of events that occurs with psychosis. …

… as trial registries were searched for placebo-controlled trials. … striatal dopamine release in
response to rewarding stimuli … interest to modulate dopaminergic neurotransmission for the …

… Also, disorders linked with aberrant dopamine function such as schizophrenia or Parkinson’…
retrieval-specific dopaminergic effects. To bridge this gap, we designed a placebo-controlled …

… modulation and the development of subthreshold psychosis. … dopamine hypothesis of
schizophrenia, where dopaminergic … to the development of schizophrenia spectrum disorders. …

… processing, thought to be due to disrupted striatal and dopaminergic function. Consistent …
striatum during reward anticipation in schizophrenia. Dopamine neuron activity is modulated by …

… management of schizophrenia, an important question is whether DA D 2 receptor antagonists
modulate … activity within the mesolimbic DA reward system. Nicotine stimulates DA neurons …

… Using a double-blind, placebo-controlled design, we analyzed … pathway and 2) transient
dopamine enhancement would … disorders such as addiction or schizophrenia [eg, (47,48)]. …